TipRanks
Verastem (DE:2VSA)
FRANKFURT:2VSA

Compare Verastem (2VSA) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Verastem
€6.17
€635.43M
-3.13
-5.26%
6 Buy
0 Hold
0 Sell
Strong Buy
Puma Biotechnology
$9.24
$507.94M
17.74
82.18%
0 Buy
1 Hold
0 Sell
Hold
CytomX Therapeutics
$3.37
$573.08M
-5.69
-21.95%
4 Buy
0 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$9.60
$485.82M
39.00
-20.06%
5 Buy
6 Hold
0 Sell
Moderate Buy
Allogene Therapeutics
$2.17
$532.06M
-2.24
16.28%
6 Buy
1 Hold
0 Sell
Strong Buy
BridgeBio Oncology Therapeutics
$9.37
$315.89M
>-0.01
-68.73%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2VSA
Verastem
6.92
-0.53
-7.17%
PBYI
Puma Biotechnology
9.51
4.48
89.07%
CTMX
CytomX Therapeutics
2.56
-0.72
-21.95%
ARVN
Arvinas Holding Company
7.41
-2.21
-22.97%
ALLO
Allogene Therapeutics
1.50
0.12
8.70%
BBOT
BridgeBio Oncology Therapeutics
3.89
-8.64
-68.95%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts